Coriell Institute for Medical Research
Coriell Institute of Medical Research
  • Request a Quote
  • Donate
  • Login
  • View Cart
Sample Catalog | Custom Services | Core Facilities | Genomic Data Search
  • Biobank
    • NIGMS
    • NINDS
    • NIA
    • NHGRI
    • NEI
    • Allen Cell Collection
    • Rett Syndrome iPSC Collection
    • Autism Research Resource
    • HD Community Biorepository
    • CDC Cell and DNA
    • J. Craig Venter Institute
    • Orphan Disease Center Collection
    • All Biobanks
  • Research
    • Overview
    • Meet Our Scientists
      • Our Faculty
      • Our Scientific Staff
    • Camden Cancer Research Center
    • Epigenetic Therapies SPORE
    • Core Facilities
    • Epigenomics
    • Camden Opioid Research Initiative (CORI)
    • The Issa & Jelinek Lab
    • The Jian Huang Lab
    • The Luke Chen Lab
      • The Lab
      • The Team
      • Publications
    • The Scheinfeldt Lab
    • The Shumei Song Lab
    • The Nora Engel Lab
      • The Lab
      • The Team
      • Publications
    • Publications
  • Services
    • Overview
    • Biobanking Services
      • Core Services
      • Project Management
      • Research Support Services
      • Sample Cataloging
      • Sample Collection Kits
      • Sample Data Management
      • Sample Distribution
      • Sample Management
      • Sample Procurement
      • Sample Storage
    • Bioinformatics and Biostatistics Services
    • Cellular and Molecular Services
      • Biomarker Research Solutions
      • Cell Culture
      • Nucleic Acid Isolation and Quality Control
    • Clinical Trial Support
      • Overview
      • Sample Collection
      • Data Management
      • Sample Processing and QC
      • Storage and Distribution
      • Biomarker Services
      • Data Analaysis
    • Core Facilties
      • Overview
      • Animal and Xenograft
      • Bioinformatics and Biostatistics
      • Cell Imaging
      • CRISPR Gene Engineering
      • Flow Cytometry and Cell Sorting
      • Genomics and Epigenomics
      • iPSC - Induced Pluripotent Stem Cells
      • Organoids
    • Coriell Marketplace
    • Genomic, Epigenomic and Multiomics Services
    • Stem Cells and iPSC Services
      • Core Services
      • Reprogramming
      • Characterization and Quality Control
      • Differentiated Cell Lines
      • iPSC-Derived Organoids
      • iPSC Expansion
      • iPSC Gene Editing
  • Ordering
    • Stem Cells
    • Cell Lines
    • DNA and RNA
    • Featured Products
      • FFPE
      • HMW DNA
    • Genomic Data Search
    • Search by Catalog ID
    • Help
      • Create Account
      • Order Online
      • Ordering FAQ
      • FAQs/Culture Instructions
      • Reference Materials
        • Biobanks
        • NIGMS Repository
        • NHGRI Repository
        • NINDS Repository
        • NIA Repository
        • NIST
        • GeT-RM
      • Secondary Distribution Policies
      • MTA Assurance Form
      • Shipment Policy
      • Contact Customer Service
  • About Us
    • Our History
    • Meet Our Team
    • Meet Our Board
    • Education
      • Science Fair
      • Summer Experience
      • Outreach
      • Research Program Internship
    • Press Room
      • Press Releases
      • Coriell Blog
      • Annual Report
    • Careers
      • Working at Coriell
    • Giving
      • Donate
      • Giving FAQ
    • Contact Us
    • Legal Notice
  • Login View Cart
search submit
  • Enzyme

Enzyme

ADA
https://enzyme.expasy.org/EC/3.5.4.4

Catalog IDDescriptionPercent Normal ActivitySpecimen AssayedRemark
GM00469SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY1 According to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM01390SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY  According to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM01671CARTILAGE-HAIR HYPOPLASIA; CHH fibroblastsAccording to the submitter, biochemical test results for this subject showed increased enzyme activity.
GM01715SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY1RBCsAccording to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM01997SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY fibroblasts/lymphoblastsAccording to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM02028SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY50RBCsAccording to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM02294SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY10-15lymphoblastsAdrian et al (Mol Cell Biol 4:1712-1717 1984) performed S1 endonuclease cleavage of ADA cDNA-mRNA hybrids to show that the ADA mRNA from this culture yielded fragments that were distinctly different from ADA mRNA fragments from normal controls. The ADA cDNA utilized for these experiments represented the complete mRNA sequence with the possible exception of some of the 5 prime untranslated region. Hirschhorn et al (J Clin Invest 71:1887-1892 1983) reported that the ADA activity for this cell culture was 10-15% of normal and had a diminished heat stability. The enzyme showed a normal electrophoretic mobility but had a more basic isoelectric point than normal (5.0 vs 4.9).
GM02433SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY fibroblasts/lymphoblasts/RBCsAccording to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM02434SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY<1.5amniotic fluidAccording to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM02436SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY fibroblastsAccording to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM02445SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY1RBCsAccording to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM02445SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY18mixed mononuclear cellsAccording to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM02446SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY fibroblasts/RBCsAccording to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM02471SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY<1.5amniotic fluidAccording to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM02472SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY fibroblasts/lymphoblasts/RBCsAccording to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM02578SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY1lymphoblasts/RBCsAccording to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM02580SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY50 According to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM02581SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY50 According to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM02582SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY50 According to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM02583SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY50 According to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM02605SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY fibroblasts/lymphoblasts/RBCsAccording to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM02606SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY fibroblasts/lymphoblasts/RBCsAccording to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM02607SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY fibroblasts/lymphoblastsAccording to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM02608SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY fibroblasts/lymphoblastsAccording to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM02609SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY fibroblasts/lymphoblastsAccording to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM02610SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY fibroblasts/lymphoblastsAccording to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM02756SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY<5lymphoblastsWiginton et al (J Biol Chem 257:3211-3217 1982) observed that this cell culture contained < 5% of normal ADA activity and immunoreactive protein. Adrian et al (Hum Genet 68:169-172 1984) reported that this ADA-deficient cell culture had normal relative levels of ADA mRNA. Sequence analysis of cDNA clones synthesized from ADA mRNA from this culture revealed a different point mutation in each allele that causes amino acid changes. In one allele amino acid 329 is changed from alanine to valine (GCG>GTG at position #1081). In the second allele amino acid 211 is changed from arginine to histidine (CGT>CAT at position 727). In addition to these point mutations each allele has a point mutation in the third base of a codon that does not alter the amino acid encoded (Ser-110 is TCT rather than TCC and Val-629 is GTA rather than GTG). Analysis of additional clones of each of these alleles showed unusual characteristics which suggest occasional aberrant splicing of ADA pre-mRNA (Akeson et al Proc Natl Acad Sci USA 84:59475951 1987). Akeson et al (J Biol Chem 263:16291-16296 1988) inserted the mutant ADA cDNA from this cell line into an expression vector and tested it in a transient expression system. ADA mRNA transcribed from the mutant vector failed to produce significant levels of enzymatically active ADA while ADA mRNA transcribed from a vector with the normal ADA cDNA did produce high levels of enzymatically active ADA. These authors also noted that the point mutation at amino acid no. 211 (Arg to His) resulting from a point mutation at base no. 727 (G to A) was also observed in another ADA-deficient cell line (GM02606) and the mutation in amino acid no. 329 (Ala to Val) resulting from a point mutation at base no. 1081 (C to T) had been observed for a different ADA-deficient cell line (GM02825).
GM02824SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY<5lymphoblastsAccording to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM02825SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY<5lymphoblastsWiginton et al (J Biol Chem 257:3211-3217 1982) observed that this cell culture contained <5% of normal ADA activity and immunoreactive protein. Adrian et al (Hum Genet 68:169-172 1984) reported that this ADA-deficient cell culture had normal relative levels of ADA mRNA. This ADA mRNA was found to be of abnormal size (Adrian et al Mol Cell Biol 4:1712-1717 1984). S1 nuclease mapping revealed two ADA mRNA bands of equal intensity. One of these bands was full-length ADA mRNA and the other band was shorter lacking exon 4. Upon analysis of cDNA synthesized from this culture ADA mRNA revealed a point mutation in the allele which produced the full-length mRNA. This mutation at base 1081 (GCG>GTG) changes amino acid 329 from alanine to valine. Several of the ADA cDNA clones extended 5 prime of the major initiation start site indicating multiple start sights for ADA transcription. Blot hybridization of genomic DNA eliminated the possibility of a large deletion in the gene that included exon 4. Isolation and sequence analysis of cDNAs corresponding to this allele showed no mutations within the remaining exons that would alter the amino acid sequence. Akeson et al (Proc Natl Acad Sci USA 84:5947-5951 1987) concluded that it seemed likely that mutation(s) within intron 3 and/or intron 4 caused deletion of exon 4 during the splicing process. The deletion of exon 4 does not alter the translational reading frame but it is likely that any protein produced would be rapidly degraded. Akeson et al (J Biol Chem 263:16291-16296 1988) reported that sequence analysis of polymerase chain reaction-amplified DNA from this culture showed a single base mutation of A to G within the invariant bases of the 3 prime splice site of intron 3 that could account for the missplicing of exon 4. This mutation occured in base 24971 of the ADA gene. Insertion of the mutant ADA cDNA from this cell line into an expression vector and testing in a transient expression system revealed that ADA mRNAs transcribed from the mutant vector failed to produce significant levels of enzymatically active ADA while ADA mRNA transcribed from a vector with the normal ADA cDNA did produce high levels of enzymatically active ADA. These authors also noted that the same mutation in amino acid no. 329 (Ala to Val) resulting from a point mutation in base no. 1081 (C to T) was also found in another ADA-deficient cell line (GM02756).
GM03029ADENOSINE DEAMINASE DEFICIENCY WITH NO IMMUNODEFICIENCY10-30fibroblastsAccording to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM03043ADENOSINE DEAMINASE DEFICIENCY, PARTIAL10-12lymphoblastsAccording to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM03071MYOPATHY DUE TO MYOADENYLATE DEAMINASE DEFICIENCY; MMDD0muscleAccording to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM03073MYOPATHY DUE TO MYOADENYLATE DEAMINASE DEFICIENCY; MMDD40muscleAccording to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM03075MYOPATHY DUE TO MYOADENYLATE DEAMINASE DEFICIENCY; MMDD70muscleAccording to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM03136SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY fibroblasts/lymphoblasts/RBCsAccording to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM03137SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY fibroblasts/lymphoblasts/RBCsAccording to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM04258SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY lymphoblasts/RBCs/granulocytesAccording to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM04395SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY0RBCsAccording to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM04395SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY14fibroblastsAccording to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM04395SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY4lymphoblastsAccording to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM04396SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY0RBCsAccording to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM04396SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY14fibroblastsAccording to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM04396SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY4lymphoblastsAccording to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM04396SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY5lymphoblastsHirschhorn et al (J Clin Invest 71:1887-1892 1983) reported that the ADA activity in this cell culture was 5% of normal activity and had only a somewhat diminished heat stability. The enzyme showed a more anodal electrophoretic mobility than normal and had a lower more acidic isoelectric point (4.8 vs 4.9). As determined by HPLC there was no detectable difference in the molecular weight of the enzyme in this culture versus the ADA in normal cultures No abnormality in Km could be detected using adenosine as the substrate.
GM05816SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY<1RBCsAccording to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM05816SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY28lymphoblastsAccording to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM05817SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY50RBCsAccording to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM05817SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY91lymphoblastsAccording to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM06142ADENOSINE DEAMINASE DEFICIENCY WITH NO IMMUNODEFICIENCY<1RBCsAccording to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM06142ADENOSINE DEAMINASE DEFICIENCY WITH NO IMMUNODEFICIENCY65lymphoblastsAccording to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM06143SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY<1RBCsAccording to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM06143SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY86lymphoblastsAccording to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM06200SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY<1RBCsAccording to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM06200SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY30lymphoblastsAccording to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM06201SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY<50RBCsAccording to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM06415SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY71lymphoblastsAccording to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM06416SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY65lymphoblastsAccording to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM07103SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY0RBCsAccording to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM07103SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY16lymphoblastsAccording to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM07104SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY17RBCsAccording to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM07104SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY39lymphoblastsAccording to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM07945ADENOSINE DEAMINASE DEFICIENCY WITH NO IMMUNODEFICIENCY fibroblasts/lymphoblasts/RBCsAccording to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM08832ADENOSINE DEAMINASE DEFICIENCY WITH NO IMMUNODEFICIENCY0RBCsAccording to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM08834ADENOSINE DEAMINASE DEFICIENCY WITH NO IMMUNODEFICIENCY  According to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM10078ADENOSINE DEAMINASE DEFICIENCY WITH NO IMMUNODEFICIENCY22lymphoblastsAccording to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM10078ADENOSINE DEAMINASE DEFICIENCY WITH NO IMMUNODEFICIENCY65RBCsAccording to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM10079ADENOSINE DEAMINASE DEFICIENCY WITH NO IMMUNODEFICIENCY20lymphoblastsAccording to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM10079ADENOSINE DEAMINASE DEFICIENCY WITH NO IMMUNODEFICIENCY41RBCsAccording to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM11411SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY0.1lymphoblastsAccording to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM11411SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY0.2RBCsAccording to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM11412SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY50lymphoblastsAccording to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM11413SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY50lymphoblastsAccording to the submitter, biochemical test results for this subject showed decreased enzyme activity.

Our mission is to prevent and cure disease through biomedical research.

CONTACT US

CUSTOMER SERVICE
customerservice@coriell.org (800) 752-3805 • (856) 757-4848
Subscribe to our newsletter here

Coriell Institute for Medical Research
403 Haddon Avenue Camden, NJ 08103, USA (856) 966-7377

Ⓒ 2025 Coriell Institute. All rights reserved.

  • Facebook
  • Linkedin
  • Youtube